Sarepta Therapeutics Inc. appointed Gilmore O'Neill as chief medical officer.
Most recently, O'Neill served as senior vice president of Biogen Inc. responsible for all late-stage clinical development.
Cambridge, Mass.-based Sarepta is a biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases.
